Titan Medical Inc
$
2.54
-0.02 (-0.59%)
| Volume: | 40,295 | Avg Vol (1m): | 233,636 |
| Market Cap $: | 80.43 Mil | Enterprise Value $: | 57.01 Mil |
| P/E (TTM): | 0.00 | P/B: | 0.00 |
| Earnings Power Value | 0.89 |
| Net Current Asset Value | -0.25 |
| Tangible Book | -0.25 |
| Projected FCF | -11.56 |
| Median P/S Value | 0 |
| Graham Number | 0 |
| Peter Lynch Value | 0 |
| DCF (FCF Based) | 0 |
| DCF (Earnings Based) | 0 |
YTD (-%)
Add to portfolio
Email alerts
Stock PDF
RSS
Website
Filings
Download Excel
Batch Download
Manual of Stocks™ Web
Manual of Stocks™
Manual of Stocks™ Web
Manual of Stocks™
Financial Strength : 6/10
GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
| Current | vs industry | vs history | |
|---|---|---|---|
| Cash-to-Debt | No Debt |
Cash-To-Debt ranked
higher than
91.21%
of
330
companies
in the
Medical Devices
industry.
Industry Max: 504099, Med: 2.32, Min: -16.34
TMDI:
No Debt
Ranked among companies with meaningful Cash-To-Debt only.
|
Cash-To-Debt range over the past 10 years
Min: 0.9, Med: 10000, Max: 10000
Current: 10000
|
| Interest Coverage | No Debt |
Interest Coverage ranked
higher than
91.51%
of
212
companies
in the
Medical Devices
industry.
Industry Max: 10000, Med: 66.37, Min: 0.03
TMDI:
No Debt
Ranked among companies with meaningful Interest Coverage only.
| N/A |
| Piotroski F-Score | 2 |
0
1
2
3
4
5
6
7
8
9
| |
| Altman Z-Score | -11.49 |
DISTRESS
GREY
SAFE
| |
| WACC vs ROIC % |
ROIC 0%
WACC 60.29%
| ||
Profitability & Growth : 4/10
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
| Current | vs industry | vs history | |
|---|---|---|---|
| ROE % | -903.31 |
ROE ranked
lower than
100.00%
of
304
companies
in the
Medical Devices
industry.
Industry Max: 51.97, Med: 0.95, Min: -2921.66
TMDI:
-903.31
Ranked among companies with meaningful ROE only.
|
ROE range over the past 10 years
Min: -27049.7, Med: -231.47, Max: -30.86
Current: -903.31
|
| ROA % | -172.69 |
ROA ranked
lower than
94.88%
of
332
companies
in the
Medical Devices
industry.
Industry Max: 1204.95, Med: -0.26, Min: -2520.55
TMDI:
-172.69
Ranked among companies with meaningful ROA only.
|
ROA range over the past 10 years
Min: -228.21, Med: -121.71, Max: -28.06
Current: -172.69
|
| ROC (Joel Greenblatt) % | -3773868.81 |
ROC (Joel Greenblatt) ranked
lower than
99.69%
of
327
companies
in the
Medical Devices
industry.
Industry Max: 8175, Med: 3.87, Min: -323166.67
TMDI:
-3773868.81
Ranked among companies with meaningful ROC (Joel Greenblatt) only.
|
ROC (Joel Greenblatt) range over the past 10 years
Min: -3773868.81, Med: -67896.54, Max: -2298.04
Current: -3773868.81
|
| 3-Year Total EBITDA Growth Rate | 2.40 |
3-Year EBITDA Growth Rate ranked
higher than
62.50%
of
232
companies
in the
Medical Devices
industry.
Industry Max: 109.5, Med: 7.5, Min: -344.2
TMDI:
42.1
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
|
3-Year EBITDA Growth Rate range over the past 10 years
Min: -74.2, Med: -24.8, Max: 42.1
Current: 42.1
|
| 3-Year EPS w/o NRI Growth Rate | 51.90 |
3-Year EPS w/o NRI Growth Rate ranked
lower than
65.47%
of
223
companies
in the
Medical Devices
industry.
Industry Max: 241, Med: 7.8, Min: -413
TMDI:
51.9
Ranked among companies with meaningful 3-Year EPS w/o NRI Growth Rate only.
|
3-Year EPS w/o NRI Growth Rate range over the past 10 years
Min: -81, Med: -18.7, Max: 51.9
Current: 51.9
|
» TMDI's 30-Y Financials
Financials (Next Earnings Date: 2019-08-13)
Guru Trades Click for details
Guru Trades in
SEC Filings
Gurus Latest Trades with NAS:TMDI
» Interactive Chart
Peter Lynch Chart
Business Description
| Industry | Medical Devices » Medical Devices   NAICS : 334510   SIC : 3359 |
| Compare | TPE:4106 TSE:3079 XKRX:004080 ASX:OSP ASX:SOM ROCO:4745 XKRX:216280 TSE:5187 OSTO:PAX NAS:APEN OSTO:BRIG XKRX:044480 XCNQ:BLO ROCO:1752 ROCO:3218 XBRU:SEQUA XKRX:065510 XKRX:290660 XKRX:246960 XSAT:ORT B |
| Traded in other countries | TMD.Canada QTNA.Germany |
| Address | 170 University Avenue, Suite 1000, Toronto, ON, CAN, M5H 3B3 |
| Titan Medical Inc is in the research and development stage. The company operates in one business segment that is Research and Development of Sport. The Sport product is produced to address the current clinical, operational and financial limitations of the robotic platforms in the high growth robotic surgery market. The sport will expand robotic surgery into areas that are currently underserved, including general abdominal, gynecologic, urologic, and colorectal procedures. | |
Ratios
| Current | vs industry | vs history | |
|---|---|---|---|
| EV-to-EBIT | -1.13 |
EV-to-EBIT ranked
lower than
100.00%
of
174
companies
in the
Medical Devices
industry.
Industry Max: 18456.56, Med: 24.76, Min: 0.63
TMDI:
-1.13
Ranked among companies with meaningful EV-to-EBIT only.
|
EV-to-EBIT range over the past 10 years
Min: -8.09, Med: 0, Max: 1.18
Current: -1.13
|
| EV-to-EBITDA | -1.13 |
EV-to-EBITDA ranked
lower than
100.00%
of
188
companies
in the
Medical Devices
industry.
Industry Max: 18456.56, Med: 18.14, Min: 0.62
TMDI:
-1.13
Ranked among companies with meaningful EV-to-EBITDA only.
|
EV-to-EBITDA range over the past 10 years
Min: -8.1, Med: 0, Max: 1.18
Current: -1.13
|
| Current Ratio | 0.86 |
Current Ratio ranked
lower than
83.02%
of
324
companies
in the
Medical Devices
industry.
Industry Max: 563.8, Med: 2.71, Min: 0.03
TMDI:
0.86
Ranked among companies with meaningful Current Ratio only.
|
Current Ratio range over the past 10 years
Min: 0.56, Med: 3.81, Max: 35
Current: 0.86
|
| Quick Ratio | 0.86 |
Quick Ratio ranked
lower than
67.59%
of
324
companies
in the
Medical Devices
industry.
Industry Max: 563.8, Med: 2.03, Min: 0.02
TMDI:
0.86
Ranked among companies with meaningful Quick Ratio only.
|
Quick Ratio range over the past 10 years
Min: 0.56, Med: 3.81, Max: 35
Current: 0.86
|
Dividend & Buy Back
| Current | vs industry | vs history | |
|---|---|---|---|
| 3-Year Share Buyback Rate | -77.40 |
3-Year Share Buyback Rate ranked
lower than
88.11%
of
244
companies
in the
Medical Devices
industry.
Industry Max: 19.2, Med: -5.7, Min: -1393.3
TMDI:
-77.4
Ranked among companies with meaningful 3-Year Share Buyback Rate only.
|
3-Year Share Buyback Rate range over the past 10 years
Min: -246.9, Med: -23.3, Max: -13
Current: -77.4
|
Valuation & Return
| Current | vs industry | vs history | |
|---|---|---|---|
| Earnings Yield (Joel Greenblatt) % | -88.21 |
Earnings Yield (Greenblatt) ranked
lower than
90.06%
of
332
companies
in the
Medical Devices
industry.
Industry Max: 158.73, Med: 0.74, Min: -2500
TMDI:
-88.21
Ranked among companies with meaningful Earnings Yield (Greenblatt) only.
|
Earnings Yield (Greenblatt) range over the past 10 years
Min: -21379.49, Med: 0, Max: 49337.28
Current: -88.21
|
More Statistics
Analyst Estimate
Piotroski F-Score Details
| Piotroski F-Score | 2 |
| Positive ROA | N |
| Positive CFROA | N |
| Higher ROA yoy | Y |
| CFROA > ROA | N |
| Lower Leverage yoy | Y |
| Higher Current Ratio yoy | N |
| Less Shares Outstanding yoy | N |
| Higher Gross Margin yoy | N |
| Higher Asset Turnover yoy | N |